Keyphrases
Peripheral Blood Mononuclear Cells
100%
Mesenchymal Stem Cell-derived Exosomes
100%
Microvesicles
100%
Osteosarcoma Stem Cells
100%
Interleukin-10
33%
Interleukin-6
33%
Interleukin-2
33%
TIMP3
33%
C-X-C Motif Chemokine Ligand 13
33%
Treatment Group
11%
Group Design
11%
Days of Treatment
11%
In Vitro Study
11%
Co-cultivation
11%
Flow Cytometry
11%
Between-group
11%
Second-line Treatment
11%
Cell Apoptosis
11%
Examination Method
11%
First Treatment
11%
MSC Secretome
11%
Indirect Enzyme Linked Immunosorbent Assay
11%
Cell Environment
11%
Zero-day
11%
Neuroscience
Stem Cell
100%
Mesenchymal Stem Cell
100%
Peripheral Blood Mononuclear Cell
100%
Membrane Microparticle
100%
Osteosarcoma
100%
Interleukin 6
33%
Chemokine
33%
Interleukin 10
33%
Interleukin 2
33%
In Vitro
22%
Stromelysin
11%
Metalloprotease Inhibitor
11%
Flow Cytometry
11%
Programmed Cell Death
11%
Biochemistry, Genetics and Molecular Biology
Stem Cell
100%
Peripheral Blood Mononuclear Cell
100%
Secretome
100%
Membrane Microparticle
100%
Secretion (Process)
23%
Interleukin 6
23%
Interleukin 10
23%
Interleukin 2
23%
C-X-C Motif Chemokine 10
23%
TIMP3
15%
Enzyme
7%
In Vitro Study
7%
Coculture
7%
Metalloprotease Inhibitor
7%
Flow Cytometry
7%
Programmed Cell Death
7%
Veterinary Science and Veterinary Medicine
Stem Cell
100%
Peripheral Blood Mononuclear Cell
100%
Osteosarcoma
100%
Pharmacology, Toxicology and Pharmaceutical Science
Osteosarcoma
100%
Interleukin 10
33%
Interleukin 6
33%
Chemokine
33%
Interleukin 2
33%
Enzyme-Linked Immunosorbent Assay
11%
Flow Cytometry
11%
Tissue Inhibitor of Metalloproteinase 3
11%
Treatment Group
11%